EUVIMEDEUVIMED entdecken
Crossref

Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression

Chunying Luo, Guzhou Chen, Ruixiang Li, Shoujiao Peng, Pei Zhang, Feiyun Wang, Shaopeng Yu, Yuying Zhu, Jiange Zhang

Biochemical Pharmacology · 2024-09 · 227 · 116458

DOI: 10.1016/j.bcp.2024.116458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024-09. Verfasst von Chunying Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medici…. Hauptthemen laut MEDLINE: ELAV-Like Protein 1, Vascular Endothelial Growth Factor A, Naphthoquinones. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key Transform Program, Major Scientific and Technological Project of Zhejiang Province, Shanghai Tongji Gao Tingyao Environmental Science and Technology Development Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vasculogenic mimicry (VM) serves as a vascular-like channel that provides important substances for tumor growth and is a primary factor in glioblastoma (GBM) drug resistance. Human Antigen R (HuR)-an mRNA-binding protein-is highly expressed in GBM, closely related to tumor progression, and deemed a potential drug target. Although some small-molecule compounds have been identified to disrupt HuR binding to target mRNA, they remain in the preclinical research stage, suggesting the need for further validation and development of HuR inhibitors. In our study, we aim to screen for potential HuR inhibitors and investigate their efficacy and molecular mechanisms in GBM. We employed the fluorescence polarization method to identify HuR inhibitors from a natural compound library, confirming the efficacy of juglone in effectively inhibiting the binding of HuR to AREVegf-a. Further validation of the binding of juglone to HuR at the protein level was conducted through electrophoretic mobility shift analysis, surface plasmon resonance, and molecular docking. Furthermore, juglone demonstrated inhibitory effects on glioma growth and VM formation in vitro and in vivo. Moreover, it was observed that juglone reversed epithelial-mesenchymal transition by inhibiting the VEGF-A/VEGFR2/AKT/SNAIL signaling pathway. Finally, we established the capability of juglone to target HuR in U251 cells through HuR knockdown, mRNA stability, and cell thermal shift assays. Therefore, this study identifies juglone as a novel HuR inhibitor, potentially offering promise as a lead compound for anti-VM therapy in GBM by targeting HuR. Abbreviations: AKT, protein kinase B; ARE, adenine-and uridine-rich elements; CETSA, cellular thermal shift assay; DMEM, Dulbecco's modified Eagle's medium; ELISA, enzyme linked immune sorbent assay; EMSA, electrophoretic mobility shift assay; EMT, epithelial mesenchymal transition; FP, fluorescence polarization; GBM, glioblastoma; HTS, high-throughput screening; HuR, human antigen R; IF, Immunofluorescence; PAS, periodic acid-Schiff; PI3K, phosphoinositide-3 kinase; qRT-PCR, quantitative real-time PCR; RRMs, RNA recognition motifs; SPR, surface plasmon resonance. TMZ, temozolomide; VM, vasculogenic mimicry; VEGF-A, Vascular endothelial growth factor-A; VEGFR2, Vascular endothelial growth factor receptor-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ELAV-Like Protein 1Vascular Endothelial Growth Factor ANaphthoquinonesHumansAnimalsMiceCell Line, TumorMice, NudeGliomaBrain NeoplasmsGene Expression Regulation, NeoplasticNeovascularization, PathologicMice, Inbred BALB CXenograft Model Antitumor Assays

Stichwörter der Autor:innen

Epithelial-mesenchymal transitionGlioblastomaHuRJugloneVasculogenic mimicry

Substanzen

ELAV-Like Protein 1Vascular Endothelial Growth Factor AELAVL1 protein, humanNaphthoquinonesjugloneVEGFA protein, human

Autor:innen und Institutionen

  • The Research Center of Chiral Drugs, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai Frontiers Science Center for Trad…

Förderung

  • National Key Transform Program
  • Major Scientific and Technological Project of Zhejiang Province
  • Shanghai Tongji Gao Tingyao Environmental Science and Technology Development Foundation
  • SHUTCM
  • Shanghai Science and Technology Development Foundation
  • Key Laboratory of Bioorganic Chemistry and Molecular Engineering, Ministry of Education

Zitieren

APA

Luo, C., Chen, G., Li, R., Peng, S., Zhang, P., Wang, F., Yu, S., Zhu, Y., & Zhang, J. (2024). Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression. Biochemical Pharmacology, 227, 116458. https://doi.org/10.1016/j.bcp.2024.116458

Vancouver

Luo C, Chen G, Li R, Peng S, Zhang P, Wang F, et al. Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression. Biochemical Pharmacology. 2024;227:116458. doi:10.1016/j.bcp.2024.116458

BibTeX
@article{Luo2024,
  author = {Luo, Chunying and Chen, Guzhou and Li, Ruixiang and Peng, Shoujiao and Zhang, Pei and Wang, Feiyun and Yu, Shaopeng and Zhu, Yuying and Zhang, Jiange},
  title = {Juglone suppresses vasculogenic mimicry in glioma through inhibition of HuR-mediated VEGF-A expression},
  journal = {Biochemical Pharmacology},
  year = {2024},
  volume = {227},
  pages = {116458},
  doi = {10.1016/j.bcp.2024.116458}
}
Kostenlos starten →